These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 18477456)
1. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Zhang JL; Qiu LY; Kotzsch A; Weidauer S; Patterson L; Hammerschmidt M; Sebald W; Mueller TD Dev Cell; 2008 May; 14(5):739-50. PubMed ID: 18477456 [TBL] [Abstract][Full Text] [Related]
2. The binding of von Willebrand factor type C domains of Chordin family proteins to BMP-2 and Tsg is mediated by their SD1 subdomain. Fujisawa T; Huang Y; Sebald W; Zhang JL Biochem Biophys Res Commun; 2009 Jul; 385(2):215-9. PubMed ID: 19450552 [TBL] [Abstract][Full Text] [Related]
3. Binding between Crossveinless-2 and Chordin von Willebrand factor type C domains promotes BMP signaling by blocking Chordin activity. Zhang JL; Patterson LJ; Qiu LY; Graziussi D; Sebald W; Hammerschmidt M PLoS One; 2010 Sep; 5(9):e12846. PubMed ID: 20886103 [TBL] [Abstract][Full Text] [Related]
5. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins. Ahmed S; Metpally RP; Sangadala S; Reddy BV J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990 [TBL] [Abstract][Full Text] [Related]
6. The clip-segment of the von Willebrand domain 1 of the BMP modulator protein Crossveinless 2 is preformed. Fiebig JE; Weidauer SE; Qiu LY; Bauer M; Schmieder P; Beerbaum M; Zhang JL; Oschkinat H; Sebald W; Mueller TD Molecules; 2013 Sep; 18(10):11658-82. PubMed ID: 24071977 [TBL] [Abstract][Full Text] [Related]
8. The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII. de Caestecker MP; Bottomley M; Bhattacharyya S; Payne TL; Roberts AB; Yelick PC Biochem Biophys Res Commun; 2002 May; 293(5):1556-65. PubMed ID: 12054694 [TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms. Zhang JL; Huang Y; Qiu LY; Nickel J; Sebald W J Biol Chem; 2007 Jul; 282(27):20002-14. PubMed ID: 17483092 [TBL] [Abstract][Full Text] [Related]
10. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Sebald W; Nickel J; Zhang JL; Mueller TD Biol Chem; 2004 Aug; 385(8):697-710. PubMed ID: 15449706 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. Scheufler C; Sebald W; Hülsmeyer M J Mol Biol; 1999 Mar; 287(1):103-15. PubMed ID: 10074410 [TBL] [Abstract][Full Text] [Related]
12. Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand. Saremba S; Nickel J; Seher A; Kotzsch A; Sebald W; Mueller TD FEBS J; 2008 Jan; 275(1):172-83. PubMed ID: 18070108 [TBL] [Abstract][Full Text] [Related]
13. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome. Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401 [TBL] [Abstract][Full Text] [Related]
14. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4. Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215 [TBL] [Abstract][Full Text] [Related]
15. The crossveinless gene encodes a new member of the Twisted gastrulation family of BMP-binding proteins which, with Short gastrulation, promotes BMP signaling in the crossveins of the Drosophila wing. Shimmi O; Ralston A; Blair SS; O'Connor MB Dev Biol; 2005 Jun; 282(1):70-83. PubMed ID: 15936330 [TBL] [Abstract][Full Text] [Related]
16. The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding. Hauburger A; von Einem S; Schwaerzer GK; Buttstedt A; Zebisch M; Schräml M; Hortschansky P; Knaus P; Schwarz E FEBS J; 2009 Nov; 276(21):6386-98. PubMed ID: 19804412 [TBL] [Abstract][Full Text] [Related]
17. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. Allendorph GP; Isaacs MJ; Kawakami Y; Izpisua Belmonte JC; Choe S Biochemistry; 2007 Oct; 46(43):12238-47. PubMed ID: 17924656 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases. Mac Sweeney A; Gil-Parrado S; Vinzenz D; Bernardi A; Hein A; Bodendorf U; Erbel P; Logel C; Gerhartz B J Mol Biol; 2008 Dec; 384(1):228-39. PubMed ID: 18824173 [TBL] [Abstract][Full Text] [Related]
19. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites. Schreuder H; Liesum A; Pohl J; Kruse M; Koyama M Biochem Biophys Res Commun; 2005 Apr; 329(3):1076-86. PubMed ID: 15752764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]